Mark Sheptoff Financial Planning, LLC Neurocrine Biosciences Inc Transaction History
Mark Sheptoff Financial Planning, LLC
- $182 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
95.9MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.43 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.02 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$492 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$304 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$256 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $9.63B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...